CRISPR/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2/HO-1 Dependent Ferritin Activation in Glial Cells.

Saved in:
Bibliographic Details
Title: CRISPR/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2/HO-1 Dependent Ferritin Activation in Glial Cells.
Authors: Selvakumar GP; Harry S. Truman Memorial Veteans Hospital, Columbia, MO, USA.; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Ahmed ME; Harry S. Truman Memorial Veteans Hospital, Columbia, MO, USA.; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Raikwar SP; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Thangavel R; Harry S. Truman Memorial Veteans Hospital, Columbia, MO, USA.; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Kempuraj D; Harry S. Truman Memorial Veteans Hospital, Columbia, MO, USA.; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Dubova I; Harry S. Truman Memorial Veteans Hospital, Columbia, MO, USA.; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Saeed D; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Zahoor H; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Premkumar K; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Zaheer S; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Iyer S; Harry S. Truman Memorial Veteans Hospital, Columbia, MO, USA.; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA., Zaheer A; Harry S. Truman Memorial Veteans Hospital, Columbia, MO, USA. zaheera@health.missouri.edu.; Department of Neurology, and Center for Translational Neuroscience, School of Medicine, University of Missouri, M741A Medical Science Building, 1 Hospital Drive, Columbia, MO, USA. zaheera@health.missouri.edu.
Source: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology [J Neuroimmune Pharmacol] 2019 Dec; Vol. 14 (4), pp. 537-550. Date of Electronic Publication: 2019 Feb 27.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101256586 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-1904 (Electronic) Linking ISSN: 15571890 NLM ISO Abbreviation: J Neuroimmune Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1557-1904
DOI:10.1007/s11481-019-09833-6